Stockhub

Faron Pharmaceuticals Oy: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 September 2022

  • curprev 10:1310:13, 3 September 2022 95.149.241.133 talk 1,013 bytes +1,013 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, a..."
Retrieved from "https://stockhub.co/research/Faron_Pharmaceuticals_Oy"